首页> 外文会议>China-Japan Symposium on Pharmaceutical Preparations and Particulate Design >The Effect of Poly (Aspartic Acid-co-Lactic Acid) Nanospheres on the Lung Metastasis of B16-BL6 Melanoma Cells by Intravenous Administration
【24h】

The Effect of Poly (Aspartic Acid-co-Lactic Acid) Nanospheres on the Lung Metastasis of B16-BL6 Melanoma Cells by Intravenous Administration

机译:聚(天冬氨酸 - 共乳酸)纳米球对静脉施用肺转移对B16-BL6黑色素瘤细胞肺转移的影响

获取原文

摘要

Poly (aspartic acid-co-lactic acid) (PAL) [1] has been investigated as a new biodegradable material for Drug Delivery Systems (DDS) for some time. Similar to the poly (lactic acid-co-glycolic acid) (PLGA) nanospheres, the PAL nanospheres [2] can controlled-release encapsulated drugs by hydrolysis and adhere to the mucous membranes to improve the drug absorption. In this study, the vitamins encapsulated PAL nanospheres were applied on mice to examine their effect on tumor metastasis and safety as an injectable DDS material for anti-cancer and other drugs. The mouse melanoma B16BL6 cells have shown a great tendency of metastasizing to the lungs via the tail vein in a model that created experimental lung metastatic tumors. This experiment investigated the effects of PAL nanospheres on the tumor metastasis, when being administered with mouse melanoma B16BL6 cells. The experimental results suggested that PAL nanospheres administered intravenously were highly safe and did not promote the metastasis of melanoma cells to the lungs.
机译:已经研究了聚(天冬氨酸 - 共乳酸)(PAL)[1]作为药物递送系统(DDS)的新可生物降解材料一段时间。与聚(乳酸二乙醇酸)(PLGA)纳米球相似,PAL纳米球[2]可以通过水解控制释放包封的药物并粘附到粘膜上以改善药物吸收。在该研究中,将维生素包封在小鼠上涂抹了PAL纳米球,以检查它们对肿瘤转移和安全的影响,作为抗癌和其他药物的可注射DDS材料。小鼠黑色素瘤B16B16细胞显示出通过在产生实验性肺转移瘤的模型中通过尾静脉转移到肺部的巨大趋势。当用小鼠黑色素瘤B16B16细胞施用时,该实验研究了PAL纳米球对肿瘤转移的影响。实验结果表明,静脉内施用的Pal纳米球非常安全,并未促进黑色素瘤细胞转移到肺部。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号